Therefore, this study explored the correlation between EGFR mutation status and VTE and used machine learning algorithms to determine the optimal combination of biomarkers to predict the risk of VTE in patients with NSCLC undergoing surgery and postoperative thromboprophylaxis. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.